Abstract.
 Screening for protein-truncating mutations of the BRCA1 and BRCA2 genes is useful in genetic testing for familial breast cancer because, first, the methods are usually simple and not expensive, and second, the detected mutations indicate pathogenic mutations in general. We evaluated the diagnostic accuracy of the stop codon (SC) assay for detecting protein-truncating mutations in the BRCA1 and BRCA2 genes by comparing the results with DNA sequencing in samples from 29 patients with breast cancer from 24 Japanese families with a history of breast cancer. Protein-truncating mutations were detected in 5 of the 24 families (20.8%; two in the BRCA1 gene and three in the BRCA2 gene). Among the 176 DNA fragments examined using the SC assay, the existence of three protein-truncating mutations (one in the BRCA1 gene and two in the BRCA2 gene) was predicted correctly by the assay. Only one reverse transcriptase-polymerase chain reaction fragment was positive for the SC assay but was negative using DNA sequencing. Our study showed clearly that the SC assay is sensitive (3 of 3, 100%) and specific (172 of 173, 99%) for detecting pathogenic protein-truncating mutations in the BRCA1 and BRCA2 genes, and that it could be useful for screening larger populations.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Additional information
Received: October 9, 2002 / Accepted: December 3, 2002
Acknowledgments We are grateful to our patients for participating in this study and we thank all of the physicians who provided clinical samples. We also wish to thank Yuka Fujimaki for technical assistance.
Correspondence to:C. Ishioka
Rights and permissions
About this article
Cite this article
Sakayori, M., Kawahara, M., Shiraishi, K. et al. Evaluation of the diagnostic accuracy of the stop codon (SC) assay for identifying protein-truncating mutations in the BRCA1 and BRCA2 genes in familial breast cancer. J Hum Genet 48, 130–137 (2003). https://doi.org/10.1007/s100380300020
Published:
Issue Date:
DOI: https://doi.org/10.1007/s100380300020
This article is cited by
-
Monoallelic characteristic-bearing heterozygous L1053X in BRCA2 gene among Sudanese women with breast cancer
BMC Medical Genetics (2017)
-
OLA1 gene sequencing in patients with BRCA1/2 mutation-negative suspected hereditary breast and ovarian cancer
Breast Cancer (2017)
-
An Integrated in Silico Approach to Analyze the Involvement of Single Amino Acid Polymorphisms in FANCD1/BRCA2-PALB2 and FANCD1/BRCA2-RAD51 Complex
Cell Biochemistry and Biophysics (2014)
-
BRCA1 and BRCA2 germline mutations in 85 Iranian breast cancer patients
Familial Cancer (2012)
-
Three cases of kindred with familial breast cancer in which carrier detection by BRCA gene testing was performed on family members
Breast Cancer (2012)